Nature of Acquired Immune Responses, Epitope Specificity and Resultant Protection from SARS-CoV-2
The primary global response to the SARS-CoV-2 pandemic has been to bring to the clinic as rapidly as possible a number of vaccines that are predicted to enhance immunity to this viral infection. While the rapidity with which these vaccines have been developed and tested (at least for short-term effi...
Main Authors: | Reginald M. Gorczynski, Robyn A. Lindley, Edward J. Steele, Nalin Chandra Wickramasinghe |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/12/1253 |
Similar Items
-
An intranasal vaccine targeting the receptor binding domain of SARS-CoV-2 elicits a protective immune response
by: Li Chen, et al.
Published: (2022-11-01) -
Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients
by: Bernadette Crescenzo-Chaigne, et al.
Published: (2021-12-01) -
Initiation and maintenance of acquired immunity in dry eye
by: Sun Wenxin, et al.
Published: (2024-04-01) -
Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection
by: Minami Nagai, et al.
Published: (2021-08-01) -
Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2–inactivated vaccine
by: Xiaomeng He, et al.
Published: (2023-06-01)